ArticleInternational journal of women's health2026
Maternal and Fetal Outcomes in Pregnant Women with Acute Leukemia.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Acute leukemia (AL) during pregnancy is a rare condition with limited evidence-based information available on the management. The study aims to analyze the pregnancy and fetal outcomes of pregnant women with acute leukemia diagnosed during pregnancy. Methods: In this retrospective study, 18 pregnant women who were diagnosed with AL during pregnancy from January 2013 to January 2024 were reviewed. Results: Of these patients, 6 delivered before chemotherapy while 12 received chemotherapy after induced abortion. Six fetus were born through spontaneous delivery or cesarean section, and one died 3 days after birth. Fourteen patients (77.8%) were found to have decreased platelets by full blood count test. The delivery group had a longer gestational age, longer time from pregnancy termination to chemotherapy compared to the abortion group. The median age of the rest 5 newborns was 32 months. Five newborns were healthy without any deformities or developmental issues. With a median follow-up of 3 years, the overall survival (OS) rates for 18 patients with acute leukemia were estimated at 88.2%. Patients in the delivery group had a significantly lower OS rate compared to those in abortion group. Overall, starting chemotherapy as soon as possible can improve OS rates for pregnant women with AL. Conclusion: Collectively, we suggest that for pregnant patients diagnosed in early or late stages of pregnancy (after 30 weeks), opting for termination of pregnancy before starting chemotherapy could lead to better outcomes for the mothers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.